ROCHE_WEB THUMBNAIL
April 16, 2024

Faricimab – The Fight Against Retinal Diseases

Faricimab (Vabysmo) is the first approved bispecific antibody uniquely engineered to block two key pathways driving retinal vascular disease by…

popular posts
ROCHE_WEB THUMBNAIL
April 16, 2024

Faricimab – The Fight Against Retinal Diseases

latest posts
Aflibercept Receives Approval for Proactive Treat and Extend Regimen
February 20, 2020

Aflibercept Receives Approval for Proactive Treat-and-Extend Regimen

Déjà Vu Secondary Glaucoma after Pars Plana Vitrectomy
February 20, 2020

Déjà Vu Secondary Glaucoma after Pars Plana Vitrectomy

iStock 908333824
February 20, 2020

Extending Horizons in the Management of nAMD and PCV

iStock 953789788
February 20, 2020

Evidence of an Association Between Macular Degeneration and Thyroid Cancer in the Older Population

iStock 932157564
February 20, 2020

Beyond the combat zone

iStock 974812572
February 20, 2020

The Role of JNK Pathway in Retinal Degeneration and Vision Loss

iStock 514564299
February 20, 2020

Navigating the Anterior Vitreous

iStock 169944301
February 20, 2020

Retinitis Pigmentosa Treatment

Discover our fascinating content at issuu

explore